MedTrace Logo

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

NCT02357849 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2023-11-15

Study results available
· View outcomes & findings →

Summary

We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.

Conditions

  • Attenuated Psychosis Syndrome

Interventions

DRUG

Aripiprazole

see arm description

DRUG

Fluoxetine

see arm description

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Christoph U Correll, MD · North Shore LIJ

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2022-04-04
Completion
2022-04-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02357849 on ClinicalTrials.gov